
RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc. (RAPT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RAPT · as of Jun 8, 2026
Key Statistics
Explore RAPT Therapeutics, Inc. Data
rapt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 26.7%
The RAPT analyst consensus is Hold, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $58.00, representing -0.01% downside from the current price of $58.01.
Competitors & Peers
rapt competitorsStock Performance
Full HistoryAbout RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule t…
what is rapt therapeutics, inc. · rapt stock overview · rapt therapeutics, inc. company profile · who is rapt therapeutics, inc. ceo · rapt NASDAQ · rapt therapeutics, inc. headquarters · rapt therapeutics, inc. business segments
About Stock Overview & Key Data
RAPT Therapeutics, Inc. (RAPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 31, 2019. As of the latest trading session, RAPT stock price is $58.01, with a market capitalization of $959.3M. The stock has returned +590.54% over the past 12 months and +82.12% year-to-date.
According to 15 Wall Street analysts, the consensus rating for RAPT Therapeutics, Inc. stock is Hold, with an average 12-month price target of $58.00. In fiscal year 2024, RAPT Therapeutics, Inc. reported revenue of — and net income of -$129.9M. For detailed data — including RAPT Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, RAPT Therapeutics, Inc. (RAPT) stock price is $58.01. The stock is traded on NASDAQ under the ticker symbol RAPT. The 52-week range is $5.67 – $58.02.